Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxybutynin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 6/20 | 0.98 |
| ▸ | CHRM3 known ✓ | P20309 | 4/20 | 0.98 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.98 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.98 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.98 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.98 |
| ▸ | PKM | P14618 | 1/20 | 0.98 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.98 |
| ▸ | THPO | P40225 | 1/20 | 0.98 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Esoxybutynin SCHEMBL5690091 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Aroxybutynin SCHEMBL27093068 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL8019436 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL25751 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL1560964 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Esoxybutynin SCHEMBL290373 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL2992 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Aroxybutynin SCHEMBL25880 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL7557853 | 0.98 | CHRM2 (0.98) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL7895841 | 0.98 | CHRM2 (0.98) | MEN1RECQLPMP22KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1737539-A1 | THERAPEUTIC COMBINATION FOR TREATMENT OF ALZHEIMERS DISEASE | Warner-Lambert Company LLC (US) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005099823-A1 | THERAPEUTIC COMBINATION FOR TREATMENT OF ALZHEIMERS DISEASE | WARNER-LAMBERT COMPANY LLC (US) | 2005-10-27 | — | — | WO | disclosed |